GlassScriptPhysician profile
Jessica E Gruber
NPI 1295255115
$10,397.01
in general payments reported to CMS, 2019-2025
33 companies · $2,094 in 2025
The $2,094 reported for 2025 was more than what 77% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $248 · 2021: $664 · 2022: $2,363 · 2023: $2,519 · 2024: $2,103 · 2025: $2,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,323 · Education: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,322.90 |
| Education | $392.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,757.17 | 2019-2025 | |
| Janssen Biotech, INC. | $1,002.48 | 2021-2025 | Tremfya, Simponi, Stelara |
| Dermavant Sciences, INC. | $662.53 | 2022-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $652.32 | 2023-2025 | Zoryve |
| Incyte Corporation | $526.75 | 2021-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $476.30 | 2021-2025 | |
| Pfizer INC. | $474.54 | 2021-2025 | |
| Ucb, INC. | $459.73 | 2022-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $440.19 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $412.51 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $352.72 | 2021-2025 | |
| Leo Pharma INC. | $331.34 | 2021-2025 | Adbry, Anzupgo |
| Sun Pharmaceutical Industries INC. | $279.12 | 2023-2025 | Winlevi, Absorica Ld |
| Amgen INC. | $256.79 | 2022-2025 | Otezla, Otezla |
| Botanix Sb INC | $172.83 | 2025 | Sofdra |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $167.75 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $159.62 | 2019-2025 | Dupixent |
| Kyowa Kirin, INC. | $123.08 | 2020 | |
| Galderma Laboratories, L.P. | $110.92 | 2023-2025 | Oracea, Aklief, Epsolay |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.46 | 2023-2024 | Spevigo |
| Janssen Scientific Affairs, LLC | $72.82 | 2021 | |
| Organon LLC | $68.57 | 2025 | Vtama |
| Organogenesis INC. | $67.06 | 2023 | Puraply |
| Verrica Pharmaceuticals INC. | $54.26 | 2024 | Ycanth |
| Epi Health, LLC | $40.83 | 2022 | |
| Biofrontera INC. | $33.01 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Fresenius Kabi USA, LLC | $31.43 | 2023 | Idacio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.46 | 2021-2025 | Cabtreo, Siliq, Jublia |
| Almirall LLC | $22.87 | 2025 | Klisyri, Seysara |
| Janssen Pharmaceuticals, INC | $21.44 | 2022 | |
| Paratek Pharmaceuticals, INC. | $21.37 | 2022 | |
| Journey Medical Corporation | $18.57 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Gruber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.